FDA approves only vaccine Penbraya for treatment of meningococcal disease in adolescents
The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease
The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errors
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
Subscribe To Our Newsletter & Stay Updated